174 related articles for article (PubMed ID: 35783253)
1. Identification of NAD
Lin L; Chen L; Xie Z; Chen J; Li L; Lin A
Front Genet; 2022; 13():905238. PubMed ID: 35783253
[No Abstract] [Full Text] [Related]
2. Comprehensive analysis of a NAD+ metabolism-derived gene signature to predict the prognosis and immune landscape in endometrial cancer.
Hu D; Du J; Cheng Y; Xing Y; He R; Liang X; Li H; Yang Y
Biomol Biomed; 2024 Mar; 24(2):346-359. PubMed ID: 37688492
[TBL] [Abstract][Full Text] [Related]
3. A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma.
Jiang C; Zhou Y; Yan L; Zheng J; Wang X; Li J; Jiang X
Front Oncol; 2023; 13():1051641. PubMed ID: 36845744
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of nicotinamide adenine dinucleotide (NAD
Cai L; Ke C; Lin Z; Huang Y; Wang A; Wang S; Chen C; Zhong C; Fu L; Hu P; Chai J; Zhang H; Zhang B
J Gastrointest Oncol; 2022 Dec; 13(6):2845-2862. PubMed ID: 36636067
[TBL] [Abstract][Full Text] [Related]
5. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
6. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
Wang Y; Song F; Zhang X; Yang C
Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of NAD+ metabolism-related biomarkers in patients with diabetic peripheral neuropathy.
Ye C; Fu Y; Zhou X; Zhou F; Zhu X; Chen Y
Front Endocrinol (Lausanne); 2024; 15():1309917. PubMed ID: 38464965
[TBL] [Abstract][Full Text] [Related]
8. Identification of CD4
Ning S; Wu J; Pan Y; Qiao K; Li L; Huang Q
Front Immunol; 2022; 13():880769. PubMed ID: 35603183
[TBL] [Abstract][Full Text] [Related]
9. Integrating RNA-seq and scRNA-seq to explore the biological significance of NAD + metabolism-related genes in the initial diagnosis and relapse of childhood B-cell acute lymphoblastic leukemia.
Lin C; Xu JQ; Zhong GC; Chen H; Xue HM; Yang M; Chen C
Front Immunol; 2022; 13():1043111. PubMed ID: 36439178
[TBL] [Abstract][Full Text] [Related]
10. Development of prognostic indicator based on NAD+ metabolism related genes in glioma.
Chen X; Wu W; Wang Y; Zhang B; Zhou H; Xiang J; Li X; Yu H; Bai X; Xie W; Lian M; Wang M; Wang J
Front Surg; 2023; 10():1071259. PubMed ID: 36778644
[TBL] [Abstract][Full Text] [Related]
11. A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer.
Xu X; Wu Y; Jia G; Zhu Q; Li D; Xie K
J Ovarian Res; 2023 Jan; 16(1):5. PubMed ID: 36611197
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Autophagy-Related Signatures Identified Two Distinct Subtypes for Evaluating the Tumor Immune Microenvironment and Predicting Prognosis in Ovarian Cancer.
Chen X; Lan H; He D; Wang Z; Xu R; Yuan J; Xiao M; Zhang Y; Gong L; Xiao S; Cao K
Front Oncol; 2021; 11():616133. PubMed ID: 34041016
[TBL] [Abstract][Full Text] [Related]
13. Circulating NAD+ Metabolism-Derived Genes Unveils Prognostic and Peripheral Immune Infiltration in Amyotrophic Lateral Sclerosis.
Li C; Zhu Y; Chen W; Li M; Yang M; Shen Z; Zhou Y; Wang L; Wang H; Li S; Ma J; Gong M; Xu R
Front Cell Dev Biol; 2022; 10():831273. PubMed ID: 35155438
[No Abstract] [Full Text] [Related]
14. NAD+ associated genes as potential biomarkers for predicting the prognosis of gastric cancer.
Sun X; Wen H; Li F; Bukhari I; Ren F; Xue X; Zheng P; Mi Y
Oncol Res; 2023; 32(2):283-296. PubMed ID: 38186577
[TBL] [Abstract][Full Text] [Related]
15. An Unfolded Protein Response Related Signature Could Robustly Predict Survival Outcomes and Closely Correlate With Response to Immunotherapy and Chemotherapy in Bladder Cancer.
Zhang F; Feng D; Wang X; Gu Y; Shen Z; Yang Y; Wang J; Zhong Q; Li D; Hu H; Han P
Front Mol Biosci; 2021; 8():780329. PubMed ID: 35004850
[No Abstract] [Full Text] [Related]
16. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
Song Y; Qu H
BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analyses Identify APOBEC3A as a Genomic Instability-Associated Immune Prognostic Biomarker in Ovarian Cancer.
Xu F; Liu T; Zhou Z; Zou C; Xu S
Front Immunol; 2021; 12():749369. PubMed ID: 34745121
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of an immune prognostic signature for ovarian carcinoma.
Khadirnaikar S; Kumar P; Shukla SK
Cancer Rep (Hoboken); 2020 Aug; 3(4):e1166. PubMed ID: 32794637
[TBL] [Abstract][Full Text] [Related]
19. Identification of peripheral blood immune infiltration signatures and construction of monocyte-associated signatures in ovarian cancer and Alzheimer's disease using single-cell sequencing.
Zhao S; Ye B; Chi H; Cheng C; Liu J
Heliyon; 2023 Jul; 9(7):e17454. PubMed ID: 37449151
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer.
Zheng J; Guo J; Cao B; Zhou Y; Tong J
Cancer Cell Int; 2021 Jul; 21(1):363. PubMed ID: 34238292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
